Food is Not a Lifestyle Choice.
It is the Substrate
Your Biology Runs On.

Pick up a loaf of bread from a supermarket. Read the ingredient list. Count the items. A standard loaf will contain fifteen to twenty five ingredients. The traditional version requires four: flour, water, salt, yeast. The additional twenty ingredients are not there because they make the bread more nutritious. They are there because they extend shelf life, standardise texture across industrial batches, improve freeze-thaw stability for nationwide distribution, and reduce production costs.

Those are rational business objectives. They are not public health objectives. And the regulatory system that allowed those twenty ingredients into the food supply — the one that is supposed to protect the public — largely asked only one question about each of them.

Is it safe?

Not: is it needed? Not: what is the cumulative effect of consuming it alongside ten thousand other industrial ingredients across a lifetime? Not: does it improve the nutritional quality of the food it is added to? Just: can we demonstrate that it is unlikely to cause obvious toxicity at the dose consumed?

That question, asked with scientific rigour, produces a regulatory system that has approved approximately ten thousand intentionally added ingredients in the modern food supply. And it produces a clinical picture — visible on functional testing — that looks like widespread nutritional insufficiency in populations that are technically not starving.

The regulatory architecture that made this possible

The American GRAS designation — Generally Recognised As Safe — was created in 1958 to exempt genuinely traditional foods from unnecessary bureaucracy. Salt, butter, vinegar, wheat flour did not need federal scientists to determine whether they were safe. Centuries of human consumption had already answered that question.

What GRAS became is a different story. Modern manufacturers commission safety studies, assemble scientific evidence, hire expert panels to review the data, and conclude that their own ingredient meets the GRAS standard — without mandatory independent FDA review before the ingredient appears in food. The self-certification mechanism that was designed to protect real food from over-regulation became the pathway for ten thousand industrial ingredients into the food supply.

The trans fat history is the clearest case study in why this matters. Partially hydrogenated oils carried GRAS status for decades. They extended shelf life, survived repeated heating, and improved the texture of countless processed foods. They were GRAS. They were also, as it eventually emerged, one of the most harmful dietary changes of the twentieth century — raising LDL, lowering HDL, promoting systemic inflammation, increasing cardiovascular mortality. The question was asked correctly. It was the wrong question.

When trans fats were finally removed, they were largely replaced with refined seed oils — soybean, canola, corn, sunflower — which also carry GRAS status. The questions about oxidation products during repeated heating, the dramatic shift in omega-6 to omega-3 ratios, and the role of these oils in the inflammatory profile of the modern diet remain contested and largely outside the traditional GRAS framework. The lesson was not learned. The ingredient changed. The question didn't.

What processing actually does — beyond adding harmful things

The public conversation about ultra-processed food focuses primarily on what it adds — preservatives, emulsifiers, artificial colours, flavour systems. This is important. It is also incomplete. Processing doesn't just introduce problematic compounds. It removes beneficial ones, and it does so systematically.

The cumulative result is a food supply that is calorically adequate, nutritionally depleted, and structurally engineered to be consumed in quantities beyond satiety. It is not a failure of individual ingredients passing individual safety tests. It is a systemic consequence of designing food for industrial efficiency rather than biological function.

The stress-demand paradox — when nutritional need is highest, quality is lowest

This is the observation that I find most clinically important, and the one most absent from public discussion about ultra-processed food.

Under chronic stress and HPA dysregulation — the physiological state produced by the modern working life — the body's demand for specific nutrients increases substantially. Cortisol mobilises resources, drives inflammation, and accelerates metabolic processes that consume micronutrients at an elevated rate. The person under chronic stress needs more of precisely the nutrients that the industrial food supply systematically removes.

The ultra-processed food industry specifically targets time-poor, stressed, convenience-seeking people — which is precisely the population with the highest nutritional demand and the lowest resilience to nutritional shortfall. This is not coincidence. It is market positioning. The convenience that is sold as the solution is part of the problem it creates.

The neurotransmitter connection that nobody is joining up

The mental health crisis, the attention crisis, the sleep crisis — these are discussed as if they are social, psychological, and pharmaceutical problems. They are also biochemical problems. And the biochemistry runs directly through the food supply.

Ultra-processed food simultaneously provides inadequate precursors and depletes the cofactors required to synthesise the neurotransmitters the brain depends on for everything that determines quality of mental life. Low serotonin produces low mood, poor sleep, and impaired gut function. Low dopamine produces low motivation, poor attention, and anhedonia. Low GABA produces anxiety and sleep disruption. Low acetylcholine produces cognitive fog and poor parasympathetic tone.

These are not psychiatric diagnoses. They are downstream biochemical consequences of a nutritionally depleted diet consumed over years, in a population under chronic stress, that is further depleting the cofactors the brain needs to maintain normal neurotransmitter synthesis. The pharmaceutical response — SSRIs, stimulants, anxiolytics, sleep medications — addresses the downstream consequence rather than the upstream substrate.

I am not arguing that medication is wrong. I am arguing that the nutritional substrate of neurotransmitter synthesis is clinically relevant and almost universally ignored in the pharmacological management of mood, attention, and sleep disorders. The OAT measures several neurotransmitter metabolites directly. The blood chemistry shows the cofactor status. The dietary history reveals the supply problem. This is testable and addressable — not instead of appropriate medical care, but alongside it.

The supplement quality parallel

The same industrial logic that has corrupted food has corrupted the supplement industry. When the food supply became the problem, supplements became the proposed solution. And the supplement industry responded to that demand with the same industrial efficiency that created the food problem in the first place.

Taking industrial forms of nutrients to compensate for an industrial food supply is a partial solution at best. The form matters. Bioavailability matters. Synergistic cofactors matter. High-dose isolated supplements can resolve specific deficiencies in the short term — and in acute clinical situations there is a place for therapeutic doses. But the body was not designed to receive nutrients as isolated high-dose compounds divorced from their natural cofactor matrix. High-dose vitamin D without magnesium and K2. High-dose iron without the co-factors that manage its pro-oxidant potential. High-dose calcium without the vitamin D and K2 required for correct tissue deposition. Each intervention creates downstream imbalances that generate new interventions, and the chain lengthens.

The clinical reality — conviction and humility held simultaneously

Everything in this post is true. It is also insufficient as a clinical position on its own.

The food-as-foundation principle — that real food in appropriate diversity is the primary substrate for health, and that supplementation is a targeted intervention for documented deficiency rather than a permanent replacement for dietary quality — is correct. It is also sometimes clinically impractical in ways that matter.

The food-as-foundation position is not evangelical in the sense of being inflexible. It is a direction of travel, not a destination that must be reached in one step. The clinical work is to move consistently in that direction, using testing to identify the highest-priority interventions, and accepting that progress in one client over twelve months may look very different from progress in another. What matters is the direction, and the data that confirms the movement is producing measurable biological change.

The alternative — guessing what nutrient an untested person might be deficient in, supplementing with industrial forms of that nutrient in doses disconnected from individual need, while leaving the food supply and stress load unaddressed — is the status quo. It is also why so many people are spending significant money on supplements and feeling only marginally better.

Test what is actually depleted. Address the food supply where possible. Supplement specifically where the data shows it is needed, in forms the body can actually use. That is the clinical position. It sounds simple. In practice, it requires nearly forty years of paying attention.